Gilead Sciences: Innovative Approaches to Healthcare Can Remove Barriers
Gilead Sciences, a biopharmaceutical company focused on developing innovative medicines for unmet medical needs, emphasizes the importance of removing barriers to healthcare access. Johanna Mercier, Chief Commercial Officer, highlights Gilead's efforts to improve health equity and increase access to life-changing therapies. These initiatives align with the company's commitment to responsible business practices.
Gilead operates in over 35 countries globally, with its headquarters in Foster City, California. The company's mission is to transform and simplify care for people with life-threatening illnesses worldwide, focusing on areas of unmet medical need.
Gilead Sciences, un'azienda biofarmaceutica dedicata allo sviluppo di medicinali innovativi per rispondere a bisogni medici non soddisfatti, sottolinea l'importanza di rimuovere le barriere all'accesso alla salute. Johanna Mercier, Chief Commercial Officer, mette in evidenza gli sforzi di Gilead per migliorare l'equità nella salute e aumentare l'accesso a terapie che cambiano la vita. Queste iniziative sono in linea con l'impegno dell'azienda per pratiche commerciali responsabili.
Gilead opera in oltre 35 paesi nel mondo, con sede a Foster City, California. La missione dell'azienda è trasformare e semplificare le cure per le persone affette da malattie potenzialmente letali a livello globale, concentrandosi su aree di bisogno medico non soddisfatto.
Gilead Sciences, una compañía biofarmacéutica enfocada en desarrollar medicamentos innovadores para necesidades médicas insatisfechas, enfatiza la importancia de eliminar las barreras al acceso a la atención médica. Johanna Mercier, Directora Comercial, destaca los esfuerzos de Gilead para mejorar la equidad en salud y aumentar el acceso a terapias que cambian vidas. Estas iniciativas están alineadas con el compromiso de la empresa con prácticas comerciales responsables.
Gilead opera en más de 35 países a nivel mundial, con su sede en Foster City, California. La misión de la empresa es transformar y simplificar la atención para personas con enfermedades que amenazan la vida en todo el mundo, enfocándose en áreas de necesidad médica insatisfecha.
기레드 사이언스(Gilead Sciences)는 충족되지 않은 의료 요구를 위해 혁신적인 의약품 개발에 주력하는 생명공학 회사로서, 의료 접근성을 위한 장벽 제거의 중요성을 강조합니다. 조한나 머시어, 최고 상업 책임자는 기레드의 건강 형평성 개선 및 생명을 변화시키는 치료에 대한 접근성 증가를 위한 노력을 강조합니다. 이러한 이니셔티브는 책임 있는 비즈니스 관행에 대한 회사의 약속과 일치합니다.
기레드는 전 세계 35개국 이상에서 운영되며, 본사는 캘리포니아주 포스터 시티에 위치해 있습니다. 이 회사의 사명은 전 세계적으로 생명을 위협하는 질병을 앓고 있는 사람들을 위해 치료를 혁신하고 단순화하는 것이며, 충족되지 않은 의료 요구 분야에 집중하고 있습니다.
Gilead Sciences, une société biopharmaceutique axée sur le développement de médicaments innovants pour répondre à des besoins médicaux non satisfaits, souligne l'importance de lever les barrières à l'accès aux soins de santé. Johanna Mercier, Directrice Commerciale, met en lumière les efforts de Gilead pour améliorer l'équité en santé et augmenter l'accès à des thérapies qui changent la vie. Ces initiatives s'alignent avec l'engagement de l'entreprise envers des pratiques commerciales responsables.
Gilead opère dans plus de 35 pays dans le monde, avec son siège à Foster City, Californie. La mission de l'entreprise est de transformer et simplifier les soins pour les personnes atteintes de maladies potentiellement mortelles dans le monde entier, en se concentrant sur des domaines de besoin médical non satisfait.
Gilead Sciences, ein biopharmazeutisches Unternehmen, das sich auf die Entwicklung innovativer Medikamente zur Deckung unerfüllter medizinischer Bedürfnisse konzentriert, hebt die Bedeutung der Beseitigung von Barrieren beim Zugang zur Gesundheitsversorgung hervor. Johanna Mercier, Chief Commercial Officer, betont die Bemühungen von Gilead, die Gesundheitsgerechtigkeit zu verbessern und den Zugang zu lebensverändernden Therapien zu erhöhen. Diese Initiativen stehen im Einklang mit dem Engagement des Unternehmens für verantwortungsvolles Geschäftsgebaren.
Gilead ist in über 35 Ländern weltweit tätig, mit Hauptsitz in Foster City, Kalifornien. Die Mission des Unternehmens ist es, die Behandlung für Menschen mit lebensbedrohlichen Krankheiten zu transformieren und zu vereinfachen, wobei der Fokus auf Bereichen mit unerfülltem medizinischem Bedarf liegt.
- Global presence in over 35 countries, indicating wide market reach
- Focus on developing innovative medicines for unmet medical needs
- Commitment to improving health equity and increasing access to therapies
- None.
NORTHAMPTON, MA / ACCESSWIRE / September 4, 2024 / Transformative medicines have the greatest impact when they reach the people who need them most.
Here, Johanna Mercier, Chief Commercial Officer, shares how Gilead works to help remove barriers to care, improve health equity and increase access to life-changing therapies - all of which underscore our commitment to being a responsible company.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
Originally published by Gilead Sciences
View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.
Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: info@3blmedia.com
SOURCE: Gilead Sciences
View the original press release on accesswire.com
FAQ
What is Gilead Sciences' (GILD) approach to healthcare access?
Who is the Chief Commercial Officer of Gilead Sciences (GILD)?
Where is Gilead Sciences (GILD) headquartered?
In how many countries does Gilead Sciences (GILD) operate?
